Journal
GREEN CHEMISTRY
Volume 15, Issue 7, Pages 1708-1719Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c3gc40625c
Keywords
-
Funding
- Department of Defense through the National Defense Science and Engineering Graduate Fellowship (NDSEG) Program
- Virginia Tech Biological Systems Engineering Department, Shell GameChanger Program
- Virginia Tech CALS Biodesign and Bioprocessing Research Center
- NSF SBIR I
- DOE STTR I
Ask authors/readers for more resources
Cost-efficient production of sustainably-derived biochemicals and biofuels is a critical goal of modern biotechnology. The current predominant biotransformation method is mainly based on microbial fermentation, but this system suffers from a mismatch of engineering and cellular objectives, appropriates a significant fraction of substrate/energy sources for self-replication, and poses significant scaling challenges. Cell-free biosystems for biomanufacturing (CFB2)-complex, cell-free systems that catalyze the conversion of renewable substrates to a variety of products-are emerging as an alternative to fermentation. Within this burgeoning field, a new application is the production of low-value and high-impact biocommodities by CFB2. In this subset, synthetic enzymatic networks are capable of producing numerous desired biocommodities, with the advantages of higher product yields, faster reaction rates, and reduced interference from toxic compounds, among others. In this review, CFB2, with an emphasis on biocommodities production, is compared with microbial fermentation; current applications are presented, illustrating some of the advantages of the system; and remaining challenges are discussed with the path forward for each.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available